Oct. 21st 11:35-12:10
Solubility in the Age of a Data Lake
Mike Lovette is a Principal Engineer in Amgen’s Pivotal Drug Substance Technologies group. Mike has worked for Amgen since June 2015. He is responsible for crystallization process development within Amgen’s synthetic portfolio. In this role, he has developed a workflow platform that combines experimental best practices, contextualized data, and modelling to deliver a consistent development approach for all small molecule APIs and intermediates. Prior to joining Amgen, Mike spent 4 years at Eli Lilly in various roles within the Small Molecule Drug Development organization. Mike received his PhD under the supervision of Michael Doherty at UCSB in 2011.